Bacterial 30S ribosomal subunit 16S rRNA aminoacyl-tRNA site (16S rRNA A-site)

The bacterial 30S ribosomal subunit 16S rRNA aminoacyl-tRNA site, or A-site, is a highly conserved region within the small ribosomal subunit essential for the fidelity of protein synthesis (PubMed: 11054804). It serves as the primary decoding center where the ribosome ensures the correct matching of mRNA codons with incoming aminoacyl-tRNA anticodons. This site is the molecular target for several major classes of antibiotics used to treat severe bacterial infections (StatPearls: NBK541030). Aminoglycosides, such as gentamicin and amikacin, bind to the internal loop of the A-site, forcing the flip-out of conserved adenine residues (A1492 and A1493) into an "on" state that mimics correct base pairing; this leads to significant mRNA misreading and the production of aberrant proteins (PubMed: 11524687). Tetracyclines also target this region but act by sterically hindering the docking of aminoacyl-tRNAs, thereby halting the elongation phase of translation (PubMed: 11130071). Clinical resistance often involves the modification of the 16S rRNA by methyltransferases or the acquisition of efflux pumps and modifying enzymes, posing a significant challenge to modern antimicrobial therapy (PubMed: 24563709). Understanding the structural dynamics of the A-site remains crucial for the development of next-generation antibiotics designed to overcome existing resistance mechanisms.

Other names

16S ribosomal RNA A-siteDecoding center30S A-siteAminoacyl-tRNA binding site16S rRNA decoding site

Antibiotics targeting the 16S rRNA A-site inhibit bacterial protein synthesis by either inducing mRNA misreading through conformational changes in the decoding center (aminoglycosides) or by sterically blocking the entry of aminoacyl-tRNA into the site (tetracyclines).